BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Mar 29, 2004
 |  BioCentury  |  Strategy

All that Jazz . . .

All that Jazz . . .

Company Raised Date Focus Investors
Jazz $250.0 3/24/04 Neurology, cancer, endocrine Kohlberg Kravis Roberts; Prospect Venture Partners; Versant Ventures; Beecken Petty O'Keefe; Golden Gate Capital; Thoma Cressey Equity Partners; Adams Street Partners; EGS Healthcare Capital; Lehman Brothers; affiliate of Oak Hill
Synta $75.3 3/29/03 Cancer, autoimmune Bruce Kovner; Keith Gollust; Robert Day; Stanley Druckenmiller; Wolfensohn Family Foundation; other investors
Note: Series B had two closes: $49M on 11/13/02 and $26.3M on 3/29/03
Infinity

Read the full 492 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >